Current Ratio of Spyre Therapeutics, Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Spyre Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Spyre Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 874%, a 20% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 874% -217% -20% 30 Sep 2025
Q2 2025 806% -231% -22% 30 Jun 2025
Q1 2025 996% +633% +175% 31 Mar 2025
Q4 2024 1106% +848% +328% 31 Dec 2024
Q3 2024 1091% +910% +501% 30 Sep 2024
Q2 2024 1037% +882% +571% 30 Jun 2024
Q1 2024 362% -107% -23% 31 Mar 2024
Q4 2023 259% -228% -47% 31 Dec 2023
Q3 2023 181% -319% -64% 30 Sep 2023
Q2 2023 155% -376% -71% 30 Jun 2023
Q1 2023 469% -77% -14% 31 Mar 2023
Q4 2022 486% -50% -9.4% 31 Dec 2022
Q3 2022 501% -115% -19% 30 Sep 2022
Q2 2022 530% -162% -23% 30 Jun 2022
Q1 2022 546% -222% -29% 31 Mar 2022
Q4 2021 537% -263% -33% 31 Dec 2021
Q3 2021 616% -46% -7% 30 Sep 2021
Q2 2021 692% +118% +21% 30 Jun 2021
Q1 2021 768% +250% +48% 31 Mar 2021
Q4 2020 800% +110% +16% 31 Dec 2020
Q3 2020 662% -143% -18% 30 Sep 2020
Q2 2020 574% -328% -36% 30 Jun 2020
Q1 2020 518% -469% -47% 31 Mar 2020
Q4 2019 689% -236% -25% 31 Dec 2019
Q3 2019 805% -204% -20% 30 Sep 2019
Q2 2019 901% -178% -16% 30 Jun 2019
Q1 2019 987% -122% -11% 31 Mar 2019
Q4 2018 925% -351% -28% 31 Dec 2018
Q3 2018 1009% -457% -31% 30 Sep 2018
Q2 2018 1079% -557% -34% 30 Jun 2018
Q1 2018 1110% -711% -39% 31 Mar 2018
Q4 2017 1277% -393% -24% 31 Dec 2017
Q3 2017 1466% -174% -11% 30 Sep 2017
Q2 2017 1636% 30 Jun 2017
Q1 2017 1821% 31 Mar 2017
Q4 2016 1670% 31 Dec 2016
Q3 2016 1640% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.